Editorial comment on: botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
Kocjancic
Ervin
E
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000523:psychology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A